Foundation for Innovative New Diagnostics
The Foundation for Innovative New Diagnostics (FIND) is a global nonprofit organization headquartered in Le Grand-Saconnex, Geneva, Switzerland. Founded in 2003 with initial support from the Bill and Melinda Gates Foundation, FIND is dedicated to developing innovative and affordable point-of-care diagnostic tests for resource-limited countries and communities worldwide.
Key facts about Foundation for Innovative New Diagnostics
- EIN
- 98-0407553
- Latest 990 filing
- Form 990-PF, 2024
- Annual giving (2024)
- $1,411,110
- Grants made (2024)
- 10
- Average grant
- $141,111
- Median grant
- $40,345
- New grantees (estimate)
- 30% first-time grantees (3 of 10, 2024)
- Total assets
- $51,274,531
- Primary geography
- North Carolina (36% of itemized 2024 grant dollars)
Data from IRS Form 990-PF, 2024; updated September 2026. New grantees are estimated by matching recipient names across years (methodology).
Who Foundation for Innovative New Diagnostics funds
By grant dollars, the top recipient states for Foundation for Innovative New Diagnostics's 10 itemized 2024 grants were North Carolina (36%), California (30%) and Massachusetts (23%). The most frequent recipient cities were Cambridge, MA (2 grants). None of its 10 grants with a stated purpose were described as general or operating support.
Is Foundation for Innovative New Diagnostics open to new grantees?
30%
first-time grantees, 2024
In 2024, 3 of 10 grantees (30%) were first-time recipients. First grants averaged $121K; repeat grants $150K. How we count
Medians: $50K first-time, $40K repeat.
Estimate from itemized IRS Form 990-PF grant lists (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Next steps with Foundation for Innovative New Diagnostics
- How to evaluate Foundation for Innovative New Diagnostics as a funder
Our grant prospecting guide: read the 990-PF, check fit, and decide whether to apply.
- Draft an LOI to Foundation for Innovative New Diagnostics with AI
AI grant writing that drafts from your organization’s own materials, in your voice.
- Track this opportunity in a free grant tracker
A free Google Sheets or Excel template for deadlines, award terms, and reports due.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$51.3M
-37.0% YoY
Annual Giving
$1.4M
-74.4% YoY
Grant Count
10
-50.0% YoY
Avg Grant Size
$141K
-48.7% YoY
Mission & Focus Areas
FIND's mission is to ensure equitable access to reliable diagnosis around the world and to accelerate equitable access to reliable diagnosis around the world.
The organization works across the diagnostic value chain—from initial design through implementation in resource-limited settings. Primary focus areas include:
- Tuberculosis diagnostics: Development of rapid diagnostic tests, including cartridge-based automated tests that can diagnose disease in less than 90 minutes
- Malaria diagnostics: Evaluation and implementation of rapid diagnostic tests; FIND conducted the largest independent evaluation of malaria point-of-care diagnostic tests in partnership with the World Health Organization, evaluating 41 rapid diagnostic tests
- Human African trypanosomiasis (sleeping sickness): Three years of FIND-sponsored research identified diagnostic markers for accurate disease diagnosis
- Neglected tropical diseases: Development of easy-to-use rapid diagnostic tests for the lowest levels of health systems
- COVID-19 diagnostics: Leadership in diagnostic manufacturing advancements and technology transfer programs
- Disease X preparedness: Development of a plan for global response to and elimination of the next Disease X within 100 days of WHO declaration of a major outbreak or pandemic
- Women's healthcare diagnostics: Closing diagnostic gaps to achieve parity in women's healthcare
- AI-based diagnostics: Development of data standard frameworks
Grantmaking
FIND functions as both a grant recipient and a grant-making organization. The organization awards grants to support diagnostic development and implementation:
Ready to take the next step with Foundation for Innovative New Diagnostics?
Geographic Focus
Where this funder awards grants
FIND's work spans 25 countries globally, with particular emphasis on low- and middle-income countries (LMICs). The organization maintains regional hubs in:
- Kenya
- India
- South Africa
- Vietnam
Recent grant-making has focused on Massachusetts, California, and Washington.
Grant Distribution by State
Share of all 10 itemized 2024 grant dollars.
States
Cities
Financial History
Multi-year comparison from IRS filings
Financial Summary (Most Recent Data Available):
- Total Assets: $51,274,531 (2024 data); $81.4 million (2023 data)
- Total Liabilities: $65.3 million (2023)
- Annual Revenue: $100.0 million
- Total Giving: $12,782,246 (2024)
- Revenue (2023): $90.6 million
- Expenses (2023): $96.1 million
Tax Status: Designated as a 501(c)(3) organization; tax-exempt since October 2003; EIN: 98-0407553
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $51,274,531 | $81,417,302 | $137,542,319 |
| Revenue | $49,306,331 | $90,612,477 | $144,248,069 |
| Expenses | $56,828,646 | $96,117,239 | $146,186,498 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $2,412,155 | $3,411,063 | $961,319 |
| Distributable Amount | — | — | — |
Data update history
When this profile's IRS filing data changed on Grantable
- IRS filings on file for fiscal years 2020–2024
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
119 grants across all recorded years
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest recipients include University of North Carolina ($506,168), Diagnostic Consulting Network ($410,848), Clinton Health Access Initiative Inc ($288,213).
| Recipient | Purpose | Amount |
|---|---|---|
| UNIVERSITY OF NORTH CAROLINA Chapel Hill, NC | LABORATORY STRENGTHENING TO SUPPORT CLINICAL CARE AND RESEARCH | $506,168 |
| DIAGNOSTIC CONSULTING NETWORK Carlsbad, CA | DEVELOPMENT OF DIAGNOTIC TESTS | $410,848 |
| Clinton Health Access Initiative Inc Boston, MA | TO SUPPORT TB ELIMINATION EFFORTS | $288,213 |
| American Society of Tropical Med Oakbrook Terrace, IL | PUBLICATION OF JOURNAL SUPPLEMENT | $50,000 |
| QUANTIGEN Fisher, IN | ACCELERATING TOOLS TO DRIVE TUBERCULOSIS DETECTION | $40,570 |
| Program appropriate Tech in Health Seattle, WA | GENOMICS TRAININGS. SUPPORTING THE AFRICA CDC WORKFORCE DEVELOPMENT EFFORT FOR PATHOGEN GENOMIC SURVEILLANCE | $40,119 |
| DIMAGI INC Cambridge, MA | PRODUCTION OF MOBILE PHONE APPS THAT COLLECTS DATA FROM RAPID VITRO DIAGNOSTIC TEST AND THAT CAN AID AN RDT USER IN INTERPRETING THE TEST RESULTS | $30,457 |
| Georgetown University Center for Global Health Practice and Impact Washington, DC | DRIVING EQUITABLE ACCESS TO TESTING IN LMICS THROUGH EFFECTIVE AND AFFORDABLE TESTS AND INFRASTRUCTURE | $24,922 |
| Drugs & Diagnostics for Tropical Diseases San Diego, CA | RAPID DIAGNOSTIC TESTING FOR BURULI ULCER | $10,011 |
| HARVARD COLLEGE cambridge, MA | PROJECT AGREEMENT WITH HARVARD FOR SEQ&TREAT MUTATIONS CATALOGUE WORK | $9,802 |
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 IRS filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| Ayoade Alakija | Chairman of the Board | 1 | — |
| David Heymann | Member of the Board | 1 | — |
| Frutiger Christian | Member of the Board | 1 | — |
| Kamineni Shobana | Member of the Board | 1 | — |
| Marcel Tanner | Member of the Board | 1 | — |
| Michele Costaforlaz | Member of the Board | 1 | — |
| Precious Matsoso | Member of the Board | 1 | — |
| Rick Arthur Bright | Member of the Board (Thru 8/2024) | 1 | — |
| Soumya Swaminathan | Member of the Board (Thru 8/2024) | 1 | — |
| Cassandra Kelly-Cirino | VP, HEALTH PROGRAMMES (thru 8/24) | 40 | $191,471 |
| Dayo Adetifa | Chief Transformation Officer/CEO | 40 | $138,966 |
| Marta Fernandez Suarez | CHIEF TECHNOLOGY OFFICER (thru 10/24) | 40 | $285,980 |
| Norma Torres | CHIEF OPERATING OFFICER (thru 5/24) | 40 | $215,973 |
| Sergio Carmona | CHIEF MEDICAL OFFICER (thru 9/24) | 40 | $284,240 |
| Sharon Saacks | SENIOR DIRECTOR, PROGRAMME OPERATIONS (thru 7/24) | 40 | $230,858 |
| William Rodriguez | CHIEF EXECUTIVE OFFICER (thru 6/24) | 40 | $197,568 |
| Willo Brock | EXECUTIVE VP, EXTERNAL AFFAIRS (thru 6/24) | 40 | $163,705 |
| Darryl English | Deputy Director, Finance (Thru 11/24) | 40 | $342,536 |
| Kevin Tetteh | Director, Malaria Fever Programme | 40 | $181,958 |
| Sanjay Sarin | VP, ACCESS (thru 10/24) | 40 | $232,372 |
| Beatrice Mouton | Director, Human Resources | 40 | $260,701 |
| Brooke Nichols | Senior Director, Impact | 40 | $265,429 |
| Maria Cecilia Ferreyra Arellano | Director of AMR Programme | 40 | $213,012 |
| Morten Ruhwald | Director, Tuberculosis Programme | 40 | $244,800 |
| Shaukhat Ali Khan | Director Strategic Information | 40 | $235,091 |
| Louisa Chaubert | Director of Finance (Thru 12/23) | — | $95,808 |
Recent News & Activity
Recent developments and announcements
FIND congratulated the Kingdom of Saudi Arabia on the launch of its "Together for Health" campaign, highlighting leadership in advancing cancer prevention, early screening, and community awareness
FIND serves as a WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology Evaluation
FIND is a co-convener of the Access to COVID-19 Tools (ACT) Accelerator diagnostics pillar
FIND hosts DxConnect, an open platform for the global health community to share and track commitments supporting Member States in implementing the World Health Assembly Resolution on diagnostics
The Foundation for the National Institutes of Health Announces Research\FIND developed multiple dashboards to address fundamental data transparency and gaps in diagnostic access
The organization is highlighting the importance of diagnostics in ensuring G20 health priorities are achieved
FIND's current strategic period began in 2021, setting out vision and goals to achieve testing for healthy and safe lives
Subject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What does Foundation for Innovative New Diagnostics fund?
FIND's mission is to ensure equitable access to reliable diagnosis around the world and to accelerate equitable access to reliable diagnosis around the world. The organization works across the diagnostic value chain—from initial design through implementation in resource-limited settings. Primary focus areas include: • **Tuberculosis diagnostics**: Development of rapid diagnostic tests, including cartridge-based automated tests that can diagnose disease in less than 90 minutes • **Malaria diagno…
How do I apply for a grant from Foundation for Innovative New Diagnostics?
FIND functions as both a grant recipient and a grant-making organization. The organization awards grants to support diagnostic development and implementation: • **Typical award range**: $5,350 to $26,938,776 • **Total giving (2024)**: $12,782,246 • **Focus areas**: Education, health care, and professional societies and associations Recent grant activity includes: • **US$15.9 million grant** (with Unitaid) to improve tuberculosis diagnosis in primary care and community settings • **US$7.5 millio…
Where does Foundation for Innovative New Diagnostics make grants?
FIND's work spans 25 countries globally, with particular emphasis on low- and middle-income countries (LMICs). The organization maintains regional hubs in: • Kenya • India • South Africa • Vietnam Recent grant-making has focused on Massachusetts, California, and Washington.
What size grants does Foundation for Innovative New Diagnostics award?
In 2024, Foundation for Innovative New Diagnostics awarded 10 grants totaling $1.4M — an average of about $141K per grant, based on its IRS Form 990 filings.
What is Foundation for Innovative New Diagnostics's EIN?
Foundation for Innovative New Diagnostics's EIN (Employer Identification Number) is 98-0407553. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in Foundation for Innovative New Diagnostics's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Gates Foundation
Seattle, WA
Assets
$78.7B
Grants
4,974
Total Given
$6.3B
Johns Hopkins University
Baltimore, MD
Assets
$25.3B
Grants
813
Total Given
$594.1M
The Chicago Community Trust
Chicago, IL
Assets
$6.0B
Grants
3,976
Total Given
$1.4B
The Rockefeller Foundation
New York, NY
Assets
$6.4B
Grants
381
Total Given
$233.2M
The George Washington University
Ashburn, VA
Assets
$5.5B
Grants
191
Total Given
$54.1M
Trustees of Boston University
Boston, MA
Assets
$9.3B
Grants
268
Total Given
$109.8M
Emory University
Atlanta, GA
Assets
$22.2B
Grants
352
Total Given
$240.1M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
Assets
$83.3M
Grants
144
Total Given
$67.7M
Rheumatology Research Foundation
Atlanta, GA
Assets
$76.4M
Grants
170
Total Given
$11.6M
Gordon E and Betty I Moore Foundation
Palo Alto, CA
Assets
$11.5B
Grants
920
Total Given
$403.0M
Data last updated September 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.